US2023145207A1PendingUtilityA1
Pharmaceutical compositions comprising poh derivatives and methods of use
Est. expiryApr 19, 2037(~10.8 yrs left)· nominal 20-yr term from priority
A61K 31/20A61K 9/0048A61K 9/0043A61K 45/06A61K 47/55A61P 35/00A61K 31/045
71
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides for a method of treating a disease such as cancer, comprising the step of administering to a patient a therapeutically effective amount of a perillyl alcohol derivative such as a perillyl alcohol ester, or an isoperillyl alcohol derivative such as an isoperillyl alcohol ester. The derivative may be a perillyl alcohol or an isoperillyl alcohol conjugated with a therapeutic agent such as valproic acid. The route of administration may vary, including inhalation, intranasal, oral, transdermal, intravenous, subcutaneous or intramuscular injection.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating a disease in a mammal, the method comprising the step of administering to the mammal a therapeutically effective amount of a perillyl alcohol conjugated with valproic acid.
2 . The method of claim 1 , wherein the disease is cancer.
3 . The method of claim 2 , wherein the cancer is a tumor of the nervous system.
4 . The method of claim 3 , wherein the tumor is a glioblastoma.
5 . The method of claim 1 , further comprising the step of treating the mammal with radiation.
6 . The method of claim 1 , further comprising the step of administering to the mammal a chemotherapeutic agent.
7 . The method of claim 1 , wherein the perillyl alcohol conjugated with valproic acid is administered by inhalation, intranasally, orally, intravenously, subcutaneously or intramuscularly.
8 . A method for treating a disease in a mammal, comprising the step of administering to the mammal a therapeutically effective amount of a perillyl alcohol conjugated with valproic acid conjugated with valproic acid using a nasal delivery device.
9 . The method of claim 8 , wherein the nasal delivery device is selected from the group consisting of an intranasal inhaler, an intranasal spray device, an atomizer, a nebulizer, a metered dose inhaler (MDI), a pressurized dose inhaler, an insufflator, a unit dose container, a pump, a dropper, a squeeze bottle and a bi-directional device.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.